pyrroles has been researched along with Bare Lymphocyte Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrow, AD; Capuder, K; Cella, M; Colonna, M; Gilfillan, S; Lin, LL; Notarangelo, LD; Robinette, ML; Telliez, JB; Ulland, TK | 1 |
Borie, DC; Changelian, PS; O'Shea, JJ | 1 |
1 review(s) available for pyrroles and Bare Lymphocyte Syndrome
Article | Year |
---|---|
JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants.
Topics: Animals; Drug Design; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Janus Kinase 3; Lymphocytes; Organ Transplantation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Severe Combined Immunodeficiency; Transplantation Immunology; Transplantation, Homologous | 2004 |
1 other study(ies) available for pyrroles and Bare Lymphocyte Syndrome
Article | Year |
---|---|
Jak3 deficiency blocks innate lymphoid cell development.
Topics: Animals; Arthritis, Rheumatoid; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cells, Cultured; Humans; Immunity, Innate; Interferon-gamma; Janus Kinase 3; Killer Cells, Natural; Mice; Mice, Mutant Strains; Mutation; Phenotype; Piperidines; Pyrimidines; Pyrroles; Severe Combined Immunodeficiency | 2018 |